{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T20:51:42Z","timestamp":1770411102037,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.jvs.2009.07.108","type":"journal-article","created":{"date-parts":[[2009,12,2]],"date-time":"2009-12-02T05:08:49Z","timestamp":1259730529000},"page":"1359-1368.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Multicenter phase I\/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: The V-HEALTH study"],"prefix":"10.1016","volume":"50","author":[{"given":"Michael S.","family":"Conte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen M.","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Gaccione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indira","family":"Guleria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabir","family":"Roy-Chaudhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey H.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2009.07.108_bib1","series-title":"2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States","year":"2008"},{"key":"10.1016\/j.jvs.2009.07.108_bib2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1681\/ASN.V74523","article-title":"Hemodialysis vascular access morbidity","volume":"7","author":"Feldman","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jvs.2009.07.108_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1073-4449(12)80044-6","article-title":"The treatment of vascular access graft dysfunction: a nephrologist's view and experience","volume":"1","author":"Beathard","year":"1994","journal-title":"Adv Renal Replace Ther"},{"key":"10.1016\/j.jvs.2009.07.108_bib4","first-page":"150","article-title":"Biology of arteriovenous fistula failure","volume":"20","author":"Roy-Chaudhury","year":"2007","journal-title":"J Nephrol"},{"key":"10.1016\/j.jvs.2009.07.108_bib5","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1001\/jama.299.18.2164","article-title":"Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial","volume":"299","author":"Dember","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2009.07.108_bib6","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1681\/ASN.2005050615","article-title":"Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint","volume":"17","author":"Roy-Chaudhury","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jvs.2009.07.108_bib7","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1111\/j.1523-1755.2005.00299.x","article-title":"Inflow stenosis in arteriovenous fistulas and grafts: a multicenter, prospective study","volume":"67","author":"Asif","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.jvs.2009.07.108_bib8","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/ndt\/15.12.2029","article-title":"Treatment of stenosis and thrombosis in hemodialysis fistulas and grafts by interventional radiology","volume":"15","author":"Turmel-Rodrigues","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jvs.2009.07.108_bib9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/ndt\/18.2.378","article-title":"Prospective evaluation of failure modes in autogenous radiocephalic wrist access for hemodialysis","volume":"18","author":"Tordoir","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jvs.2009.07.108_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/(SICI)1097-4652(199708)172:2<209::AID-JCP8>3.0.CO;2-S","article-title":"Endothelial proteoglycans inhibit bFGF binding and mitogenesis","volume":"172","author":"Forsten","year":"1997","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jvs.2009.07.108_bib11","doi-asserted-by":"crossref","first-page":"29822","DOI":"10.1074\/jbc.271.47.29822","article-title":"Cellular response to transforming growth factor-beta1 and basic fibroblast growth factor depends on release kinetics and extracellular matrix interactions","volume":"271","author":"Dinbergs","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jvs.2009.07.108_bib12","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1016\/S0021-9258(18)42910-9","article-title":"Isolation and characterization of heparan sulfate proteoglycans produced by cloned rat microvascular endothelial cells","volume":"267","author":"Kojima","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jvs.2009.07.108_bib13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.surg.2006.02.008","article-title":"Role of platelet-derived growth factor and transforming growth factor beta1 the in the regulation of metalloproteinase expressions","volume":"140","author":"Borrelli","year":"2006","journal-title":"Surgery"},{"key":"10.1016\/j.jvs.2009.07.108_bib14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/jarr.2002.33519","article-title":"Hemodialysis vascular access dysfunction from basic biology to clinical intervention","volume":"9","author":"Roy-Chaudhury","year":"2002","journal-title":"Adv Renal Replace Ther"},{"key":"10.1016\/j.jvs.2009.07.108_bib15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0272-6386(97)90564-3","article-title":"Vascular access survival among incident hemodialysis patients in the United States","volume":"30","author":"Woods","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jvs.2009.07.108_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1053\/ajkd.2002.29886","article-title":"Hemodialysis vascular access survival: upper-arm native arteriovenous fistula","volume":"39","author":"Dixon","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jvs.2009.07.108_bib17","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0741-5214(94)70083-4","article-title":"Clinical in vitro endothelialization of femoropopliteal bypass grafts: an actuarial follow-up over three years","volume":"19","author":"Zilla","year":"1994","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2009.07.108_bib18","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1126\/science.2734614","article-title":"Implantation of vascular grafts lined with genetically modified endothelial cells","volume":"244","author":"Wilson","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jvs.2009.07.108_bib19","doi-asserted-by":"crossref","first-page":"8130","DOI":"10.1073\/pnas.92.18.8130","article-title":"Tissue engineered perivascular endothelial cell implants regulate vascular injury","volume":"92","author":"Nathan","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jvs.2009.07.108_bib20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1161\/01.RES.84.4.384","article-title":"Endothelial implants inhibit intimal hyperplasia after porcine angioplasty","volume":"84","author":"Nugent","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.jvs.2009.07.108_bib21","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jvs.2007.04.074","article-title":"Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts","volume":"46","author":"Nugent","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2009.07.108_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/ndt\/gfn433","article-title":"Adventitial transplantation of blood outgrowth endothelial cells in porcine hemodialysis grafts alleviates hypoxia and decreases neointimal proliferation through a matrix metalloproteinase-9-mediated pathway\u2013a pilot study","volume":"24","author":"Hughes","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jvs.2009.07.108_bib23","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1159\/000067207","article-title":"Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: a safety and efficacy study in the pig","volume":"39","author":"Nugent","year":"2002","journal-title":"J Vasc Res"},{"key":"10.1016\/j.jvs.2009.07.108_bib24","series-title":"Points to Consider in the Characterization of Cell Lines Used to Produce Biologics","year":"1993"},{"key":"10.1016\/j.jvs.2009.07.108_bib25","series-title":"Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues and Cellular and Tissue-based Products (HCT\/Ps)","year":"2007"},{"key":"10.1016\/j.jvs.2009.07.108_bib26","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1067\/mva.2002.122025","article-title":"Recommended standards for reports dealing with arteriovenous hemodialysis accesses","volume":"35","author":"Sidawy","year":"2002","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2009.07.108_bib27","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1067\/mva.2001.117890","article-title":"Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study","volume":"34","author":"Gibson","year":"2001","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2009.07.108_bib28","doi-asserted-by":"crossref","first-page":"6722","DOI":"10.1073\/pnas.97.12.6722","article-title":"Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia","volume":"97","author":"Nugent","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jvs.2009.07.108_bib29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1006\/jsre.2001.6198","article-title":"Endothelial implants provide long-term control of vascular repair in a porcine model of arterial injury","volume":"99","author":"Nugent","year":"2001","journal-title":"J Surg Res"},{"key":"10.1016\/j.jvs.2009.07.108_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2007.11.002","article-title":"Endothelial dysfunction: a key to the pathophysiology and natural history of peripheral arterial disease?","volume":"197","author":"Brevetti","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jvs.2009.07.108_bib31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ncpendmet0366","article-title":"Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes","volume":"3","author":"Rask-Madsen","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.jvs.2009.07.108_bib32","doi-asserted-by":"crossref","first-page":"69S","DOI":"10.1177\/0003319708320761","article-title":"Endothelial injury and repair: a novel theory for atherosclerosis","volume":"59","author":"Mannarino","year":"2008","journal-title":"Angiology"},{"key":"10.1016\/j.jvs.2009.07.108_bib33","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/jc.2008-2354","article-title":"Auto-antibodies in type 2 diabetes induce stress fiber formation and apoptosis in endothelial cells","volume":"94","author":"Zimering","year":"2009","journal-title":"J Clin Endocrin Metab"},{"key":"10.1016\/j.jvs.2009.07.108_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/09723757.2004.11885883","article-title":"Panel reactive antibodies in patients with neoplasia and hematological disorders","volume":"4","author":"Chhaya","year":"2004","journal-title":"Int J Hum Genet"},{"key":"10.1016\/j.jvs.2009.07.108_bib35","first-page":"38","article-title":"Alloimmunization to public HLA antigens in multi-transfused platelet recipients","volume":"16","author":"MacPherson","year":"1986","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.jvs.2009.07.108_bib36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00006254-199008000-00004","article-title":"The frequency of platelet alloantibodies in pregnant women and the occurrence and management of neonatal alloimmune thrombocytopenic purpura","volume":"45","author":"Taaning","year":"1990","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.jvs.2009.07.108_bib37","series-title":"2007 OPTN\/SRTR Annual Report: Transplant Data 1997-2006","year":"2007"},{"key":"10.1016\/j.jvs.2009.07.108_bib38","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1600-6143.2004.00360.x","article-title":"Predicting kidney graft failure by HLA antibodies: a prospective trial","volume":"4","author":"Terasaki","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jvs.2009.07.108_bib39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00007890-199001000-00019","article-title":"The significance of the anti-class I antibody response. I","volume":"49","author":"Halloran","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.jvs.2009.07.108_bib40","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1111\/j.1600-6143.2006.01472.x","article-title":"Effect of induction therapy protocols on transplant outcomes in crossmatch positive renal allograft recipients desensitized with IVIG","volume":"6","author":"Vo","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jvs.2009.07.108_bib41","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/ncpneph0239","article-title":"Vascular access for hemodialysis","volume":"2","author":"Hayashi","year":"2006","journal-title":"Nature Clin Pract"},{"key":"10.1016\/j.jvs.2009.07.108_bib42","first-page":"9","article-title":"Hemodialysis access graft failure: time to revisit an unmet clinical need?","volume":"18","author":"Rotmans","year":"2005","journal-title":"J Nephrol"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521409015791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521409015791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:13:42Z","timestamp":1760040822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521409015791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0741521409015791"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2009.07.108","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multicenter phase I\/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: The V-HEALTH study","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2009.07.108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}